Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study.
Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study.
复制标题
DOI:
10.1007/s00259-021-05327-x
复制
发表时间:
2021-10
影响因子:
9.1
通讯作者:
Howes OD
中科院分区:
文献类型:
--
作者:
Marques TR;Veronese M;Owen DR;Rabiner EA;Searle GE;Howes OD
The mitochondrial 18-kDa translocator protein (TSPO) is expressed by activated microglia and positron emission tomography enables the measurement of TSPO levels in the brain. Findings in schizophrenia have shown to vary depending on the outcome measure used and this discrepancy in TSPO results could be explained by lower non-displaceable binding (VND) in schizophrenia, which could obscure increases in specific binding. In this study, we have used the TSPO ligand XBD173 to block the TSPO radioligand [11C]-PBR28 and used an occupancy plot to quantify VND in patients with schizophrenia. A total of 7 patients with a diagnosis of schizophrenia were recruited for this study. Each patient received two separate PET scans with [11C]PBR28, one at baseline and one after the administration of the TSPO ligand XBD173. All patients were high-affinity binders (HABs) for the TSPO gene. We used an occupancy plot to quantify the non-displaceable component (VND) using 2TCM kinetic estimates with and without vascular correction. Finally we computed the VND at a single subject level using the SIME method. All patients showed a global and generalized reduction in [11C]PBR28 uptake after the administration of XBD173. Constraining the VND to be equal for all patients, the population VND was estimated to be 1.99 mL/cm3 (95% CI 1.90 to 2.08). When we used vascular correction, the fractional TSPO occupancy remained similar. In schizophrenia patients, a substantial component of the [11C]PBR28 signal represents specific binding to TSPO. Furthermore, the VND in patients with schizophrenia is similar to that previously reported in healthy controls. These results suggest that changes in non-specific binding between schizophrenia patients and healthy controls do not account for discrepant PET findings in this disorder. The online version contains supplementary material available at 10.1007/s00259-021-05327-x.
登录
查看更多内容
影响因子:
3.2
作者:
Coughlin JM;Wang Y;Ma S;Yue C;Kim PK;Adams AV;Roosa HV;Gage KL;Stathis M;Rais R;Rojas C;McGlothan JL;Watkins CC;Sacktor N;Guilarte TR;Zhou Y;Sawa A;Slusher BS;Caffo B;Kassiou M;Endres CJ;Pomper MG
通讯作者:
Pomper MG
DOI:
10.1007/s00259-015-3149-8
发表时间:
2016-01-01
影响因子:
9.1
作者:
Collste, K.;Forsberg, A.;Cervenka, S.
通讯作者:
Cervenka, S.
影响因子:
15.1
作者:
De Picker, Livia;Ottoy, Julie;Morrens, Manuel
通讯作者:
Morrens, Manuel
影响因子:
5.7
作者:
Edison, Paul;Brooks, David J.;Hinz, Rainer
通讯作者:
Hinz, Rainer
影响因子:
6.3
作者:
LASSEN, NA;BARTENSTEIN, PA;ANDERSEN, JV
通讯作者:
ANDERSEN, JV